Inozyme Pharma, Inc. (INZY) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inozyme Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
  • Inozyme Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $992 K, a 34% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $992 K -$511 K -34% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.13 M -$494 K -30.5% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $1.26 M -$478 K -27.6% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.38 M -$463 K -25.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.5 M -$447 K -22.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.62 M -$433 K -21.1% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $1.73 M -$418 K -19.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.84 M -$404 K -18% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.95 M -$391 K -16.7% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.05 M +$2.05 M Dec 31, 2021 10-K 2023-03-22
Q3 2021 $2.15 M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.25 M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $2.34 M Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.